About this Research Topic
Zoonotic diseases are particularly relevant to human health, and local outbreaks of certain diseases can have serious consequences, including the 2005 H5/N1 avian influenza outbreak, the 2009 "swine flu" H1/N1 influenza pandemic, and the 2019 COVID-19. Although viruses were responsible for these incidents, bacteria also pose threats to widespread zoonotic incidents. Bacteria are widely present in the human environment, and there are undoubtedly pathogens that can cause serious and even life-threatening infections in humans and livestock. Although humans have lived together with pathogenic bacteria for a long time, this war with pathogenic bacteria is destined to be perpetual, and we need to continue to innovate new treatments to meet the increasing challenges by discovering novel drugs, including molecular drugs, especially from traditional medicine. Tumors and other immunodeficiency diseases are also extremely harmful to animals and humans. Therefore, it is necessary to find novel drugs to treat these harmful diseases and elaborate on the mechanisms in this section. The following topics are encouraged to be submitted to this special issue.
- Exogenous miRNA derived from herbal medicine are effective against H1N1, COVID-19, and other endogenic ones derived from the host are also effective. What is the mechanism of those miRNAs?
- It is a ticklish question to overcome resistant bacterial infections such as MARS, H. parasuis, and streptococci, so it is encouraged to focus on targeting therapy using nanotechnology.
- The use of nanotechnology to combat resistant bacteria and virus infections. For example, creating targeting nanoparticles to deliver medicine targeting bacteria or the infectious microenvironment depending on the characteristics of resistant bacteria and their infectious sites would be a fascinating topic.
- Small RNA and other activated molecules discovered from herb medicine Finding new exogenous miRNA derived from plants as novel drug molecules against bacterial and viral infection, as well as investigating the mechanisms, would be a significant topic.
- Exogenous miRNA derived from herbal medicine are effective against H1N1, COVID-19, and other endogenic ones derived from the host are also effective. What is the mechanism of those miRNAs?
- It is a ticklish question to overcome resistant bacterial infections such as MARS, H. parasuis, and streptococci, so it is encouraged to focus on targeting therapy using nanotechnology.
- The use of nanotechnology to combat resistant bacteria and virus infections. For example, creating targeting nanoparticles to deliver medicine targeting bacteria or the infectious microenvironment depending on the characteristics of resistant bacteria and their infectious sites would be a fascinating topic.
- Small RNA and other activated molecules discovered from herb medicine Finding new exogenous miRNA derived from plants as novel drug molecules against bacterial and viral infection, as well as investigating the mechanisms, would be a significant topic.
Keywords: nanotechnology, Bacteria, Novel drug, virus, Zoonotic diseases
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
